|
|
Where Should We Care for the Ill Patients with Dementia?
|
|
|
Chronic Kidney Disease Management in 2023: Towards Personalized Care and Population HealthTariq Shafi, MD, MHS
|
|
|
Chronic Kidney Disease Management in 2023: Towards Personalized Care and Population HealthTariq Shafi, MD, MHS
|
|
|
Dr. Spellberg discusses the studies showing short courses of antibiotics are just as efficient as long courses in some infections.
|
|
|
Dr. Richard Robbins updates the Department on the 2021 year in review of the Department of Medicine
|
|
|
Dr. Arias will work a mystery case along with an internal medicine resident to come up with a diagnosis.
|
|
|
Dr. Singh discusses framework and approaches to measure and mitigate diagnostic errors.
|
|
|
Dr. Al-Mallah with discuss current guidelines of chest pain evaluation as well as different imaging modalities in the assessment of chest pain.
|
|
|
Nazi Doctors on Trial- Nuremberg at 75
|
|
|
Gender equity, professional opportunity concerns, and harrassment is discussed with regards to the department of medicine and nationally throughout the United States among practicing physicians and…
|
|
|
Ms. Dowdell discusses who we need to consider to advance DEI at Houston Methodist as well as the
importance of cultural competence and the different ways we are advancing DEI and how to drive…
|
|
|
Dr. Goel discussed the role of mitral transcatheter edge to edge repair (TEER) in mitral regurgitation and various newer technologies that are on the horizon in the field of transcatheter mitral…
|
|
|
Dr. Deswal describes the epidemiology of heart failure and type 2 diabetes mellitus and the impact of diabetes mellitus and its control on heart failure outcomes. She will also interpret the data on…
|
|
|
Dr. Abdelrahim will discuss the concept of Transplant Oncology, the paradigm shift in multidisciplinary GI cancer treatment, and the emerging Concepts in Transplant Oncology.
|
|
|
Dr. Ganguly and 2nd year residents work through limited laboratory and pathological findings of a mystery case to determine a diagnosis.
|
|
|
Dr. Roman discusses the rationale for the use of monoclonal antibodies in Alzheimer’s Disease. He will also discuss two main side effects of the treatment: ARIA-E and ARIA-H and how to advise…
|
|
|
Dr. Romero will discuss how Arkansas has approached distribution of anti-spike protein mAbs and its attempt for equitable access as well as the shifting epidemiology of COVID-19 in the US and its…
|
|
|
Dr. Huang discusses the biological rationale and indication for neutralizing monoclonal antibody therapy in ambulatory patients with COVID-19 infections
|
|
|
Dr. Glassner discusses the basics of IBD, epidemiological links supporting association between IBD and ASCVD, and the potential mechanisms involved in the IBD-ASCVD link
Implications for preventive…
|
|
|
Dr. Andrieni discusses the key components of value based care as well as goals of a Medicare shared savings program.
|